Skip to content

The transcriptomic profile of hemodialysis patients recieving walk training with blood flow restriction

The transcriptomic profile of hemodialysis patients recieving walk training with blood flow restriction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089628
Enrollment
Unknown
Registered
2024-09-12
Start date
2024-09-19
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

walk training with blood flow restriction:None
walk training:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. adults (age = 18 years), 2. MHD = three months, 3. hemodialysis three sessions per week, 4. ability to walk independently, 5. Normal cognitive ability, ability to understand exercise instruction, and 6. ability to read Chinese; 7. No acute complications (such as acute infection, unstable angina, acute myocardial infarction, stroke, recent fractures, etc.).

Exclusion criteria

Exclusion criteria: 1. exercise regularly (i.e., >150 minutes per week of aerobic exercise or structured resistance exercise > one session per week), 2. contraindications to exercise training (e.g., musculoskeletal factors and neurological conditions), 3. Individuals with hemodynamic instability: SBP = 180 mmHg or DBP = 105 mmHg before dialysis, rest heart rate = 120 beats per minute, symptomatic heart failure, severe arrhythmia, weight gain during dialysis interval = 4kg; 4. high risk of BFR implementation: coagulation or presence of signs of thrombophlebitis, diagnosis of peripheral vascular disease in the lower limbs, significant edema in both lower limbs, skin damage of any low limb, etc., 5. had a single-pool Kt/V (spKt/V) value of < 1.2. 6. with lower limb deep vein catheterization or lower limb arteriovenous fistula.

Design outcomes

Primary

MeasureTime frame
RNA-seq data;6-minute walking test;Dialysis adequacy ;

Secondary

MeasureTime frame
Handgrip strength (HGS);30-second sit-to-stand-to-sit test (STS30);Time up-and-go test (tug);Health-related quality of life;blood pressure;heart rate;

Countries

China

Contacts

Public ContactHuang Ying

The First Affiliated Hospital of Soochow University

yvonne1228@163.com+86 138 6212 1552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026